Pneumococcal Vaccines: A Public Health Perspective

Ospina‐Henao, Sebastián

doi:10.19080/ijoprs.2022.05.555671

Cited by 1 publication

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…VPDs are one of the main causes of illness, long-term incapacity, and deaths among children, in both developed and developing countries ( 4 ). Initially, six VPDs were covered in the EPI more than four decades ago, and at least ten more vaccines have since expanded the degree of protection provided ( 5 , 6 ). To provide indirect protection against VPDs in the population through collective immunity, a high vaccination coverage for a sustained time is required, with the percentage coverage varying depending on the disease ( 7 ).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Strategies for expanding childhood vaccination in the Americas following the COVID-19 pandemic

Domingues,

Safadi,

Espinal

et al. 2024

Revista Panamericana De Salud Pública

View full text Add to dashboard Cite

Objective. To provide an overview of the status of the childhood vaccination schedule in the Americas, outline program structures, and identify updated implementation strategies to improve vaccination coverage following the COVID-19 pandemic. Methods. A group of experts in pediatrics, epidemiology, vaccines, and global and public health discussed the current status of the childhood vaccination schedule in the Americas, describing the program structure and identifying new implementation strategies that have the potential to improve vaccination coverage in the post-pandemic context, after the challenges COVID-19 presented for more than two years. Results. The Americas currently face a high risk of resurgence of diseases that were previously controlled or eliminated. Therefore, it is important to find new strategies to educate citizens on the risks associated with lower vaccination rates, especially in children. Conclusions. New strategies along with strong mobilization of the population and advocacy by citizens are necessary to prevent antivaccination groups from gaining a stronger presence in the region and jeopardizing the credibility of the Expanded Program on Immunization.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Hib vaccine is not required for healthy children after 5 years of age. 6 For administration of pneumococcal conjugate vaccine (PCV) to infants, WHO recommends a 3-dose schedule administered either as 2p+1 or as 3p+0, starting as early as 6 weeks of age.…”

Section: Notesmentioning

confidence: 99%